Immobilized antibiotics to prevent orthopaedic implant infections

Advanced Drug Delivery Reviews

Volumn 64, Issue 12, 2012, Pages 1165-1176

  Hickok, Noreen J ^a   Shapiro, Irving M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Antibiotics; Bacteria; Implants; Orthopaedic; Staphylococcal aureus; Titanium; Vancomycin

Indexed keywords

ANIMAL MODEL; BACTERIAL COLONIZATION; BIOACTIVE SURFACES; BIOFILM FORMATION; BODY CAVITY; CHEMICAL SYNTHESIS; IMPLANT LOOSENING; METAL SURFACES; ORTHOPAEDIC IMPLANT INFECTIONS; ORTHOPAEDIC SURGERY; OSTEOBLASTIC CELL ADHESION; STAPHYLOCOCCAL AUREUS; SURGICAL PROCEDURES; VANCOMYCIN;

ANTIBIOTICS; BIOFILMS; DENTAL PROSTHESES; ORTHOPEDICS; SELF ASSEMBLED MONOLAYERS; TISSUE; TITANIUM;

BACTERIA;

3 AMINOPROPYLTRIETHOXYSILANE; ANTIBIOTIC AGENT; BONE CEMENT; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CEFTRIAXONE; COLLAGEN SPONGE; DAPTOMYCIN; DOXYCYCLINE; GENTAMICIN; GOLD; HYDROXYAPATITE; KANAMYCIN; MAIGANIN I; NETILMICIN; POLY(METHYL METHACRYLATE); SILVER; TETRACYCLINE; TITANIUM; TOXIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTHROPLASTY; BACTERIAL COLONIZATION; BIOFILM; BONE ALLOGRAFT; BONE INFECTION; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; HUMAN; IMPLANT; NONHUMAN; ORTHOPEDIC SURGERY; OSTEOBLAST; OSTEOMYELITIS; PRIORITY JOURNAL; PROSTHESIS INFECTION; REVIEW; SURGICAL INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG IMPLANTS; HUMANS; ORTHOPEDIC PROCEDURES; PROSTHESES AND IMPLANTS; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; TITANIUM;

EID: 84865303551     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.03.015     Document Type: Review

References (182)

1. Tsukayama D.T., Estrada R., Gustilo R.B. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J. Bone Joint Surg. Am. 1996, 78:512-523.
2. Peersman G., Laskin R., Davis J., Peterson M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin. Orthop. Relat. Res. 2001, 15-23.
3. Sanderson P.J. Infection in orthopaedic implants. J. Hosp. Infect. 1991, 18:367-375.
4. Darouiche R.O. Antimicrobial approaches for preventing infections associated with surgical implants. Clin. Infect. Dis. 2003, 36:1284-1289.
5. Harris L.G., Richards R.G. Staphylococci and implant surfaces: a review. Injury 2006, 37:S3-S14.
6. Anwar H., Dasgupta M.K., Costerton J.W. Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob. Agents Chemother. 1990, 34:2043-2046.
7. Duncan C.P., Masri B.A. The role of antibiotic-loaded cement in the treatment of an infection after a hip replacement. Instr. Course Lect. 1995, 44:305-313.
8. Fish D.N., Hoffman H.M., Danziger L.H. Antibiotic-impregnated cement use in U.S. hospitals. Am. J. Hosp. Pharm. 1992, 49:2469-2474.
9. Garvin K.L. Two-stage reimplantation of the infected hip. Semin. Arthroplasty 1994, 5:142-146.
10. Steinbrink K. The case for revision arthroplasty using antibiotic-loaded acrylic cement. Clin. Orthop. Relat. Res. 1990, 19-22.
11. Zhao L., Wang H., Huo K., Cui L., Zhang W., Ni H., Zhang Y., Wu Z., Chu P.K. Antibacterial nano-structured titania coating incorporated with silver nanoparticles. Biomaterials 2011, 32:5706-5716.
12. Furkert F.H., Sorensen J.H., Arnoldi J., Robioneck B., Steckel H. Antimicrobial efficacy of surface-coated external fixation pins. Curr. Microbiol. 2011, 62:1743-1751.
13. Juan L., Zhimin Z., Anchun M., Lei L., Jingchao Z. Deposition of silver nanoparticles on titanium surface for antibacterial effect. Int. J. Nanomedicine 2010, 5:261-267.
14. Hetrick E.M., Schoenfisch M.H. Reducing implant-related infections: active release strategies. Chem. Soc. Rev. 2006, 35:780-789.
15. Masse A., Bruno A., Bosetti M., Biasibetti A., Cannas M., Gallinaro P. Prevention of pin track infection in external fixation with silver coated pins: clinical and microbiological results. J. Biomed. Mater. Res. 2000, 53:600-604.
16. Mrksich M., Dike L.E., Tien J., Ingber D.E., Whitesides G.M. Using microcontact printing to pattern the attachment of mammalian cells to self-assembled monolayers of alkanethiolates on transparent films of gold and silver. Exp. Cell Res. 1997, 235:305-313.
17. Valappil S.P., Knowles J.C., Wilson M. Effect of silver-doped phosphate-based glasses on bacterial biofilm growth. Appl. Environ. Microbiol. 2008, 74:5228-5230.
18. Kassler J., Barnett J. A rehabilitation hospital's experience with ionic silver Foley catheters. Urol. Nurs. 2008, 28:97-99.
19. Coughlan A., Boyd D., Douglas C.W., Towler M.R. Antibacterial coatings for medical devices based on glass polyalkenoate cement chemistry. J. Mater. Sci. Mater. Med. 2008, 19:3555-3560.
20. De Bastiani G., Aldegheri R., Renzi Brivio L. Dynamic axial fixation. A rational alternative for the external fixation of fractures. Int. Orthop. 1986, 10:95-99.
21. Thakur A.J., Patankar J. Open tibial fractures. Treatment by uniplanar external fixation and early bone grafting. J. Bone Joint Surg. Br. 1991, 73:448-451.
22. Schroder H.A., Christoffersen H., Sorensen T.S., Lindequist S. Fractures of the shaft of the tibia treated with Hoffmann external fixation. Arch. Orthop. Trauma Surg. 1986, 105:28-30.
23. Mankin H.J., Hornicek F.J., Raskin K.A. Infection in massive bone allografts. Clin. Orthop. Relat. Res. 2005, 432:210-216.
24. C.Centers for Disease, Prevention Update: allograft-associated bacterial infections - United States. Weekly Report 2002, 51:207-210.
25. Collins I., Wilson-MacDonald J., Chami G., Burgoyne W., Vineyakam P., Berendt T., Fairbank J. The diagnosis and management of infection following instrumented spinal fusion. Eur. Spine J. 2008, 17:445-450.
26. Weinstein M.A., McCabe J.P., Cammisa F.P. Postoperative spinal wound infection: a review of 2,391 consecutive index procedures. J. Spinal Disord. 2000, 13:422-426.
27. Cierny G., DiPasquale D. Periprosthetic total joint infections: staging, treatment, and outcomes. Clin. Orthop. Relat. Res. 2002, 403:23-28.
28. Duggan J.M., Georgiadis G.M., Kleshinski J.F. Management of prosthetic joint infections. Inf. Med. 2001, 18:534-541.
29. McPherson E.J., Woodson C., Holtom P., Roidis N., Shufelt C., Patzakis M.J. Periprosthetic total hip infection: outcomes using a staging system. Clin. Orthop. Relat. Res. 2002, 403:8-15.
30. Nair S.P., Williams R.J., Henderson B. Advances in our understanding of the bone and joint pathology caused by Staphylococcus aureus infection. Rheumatology 2000, 39:821-834.
31. Pulido L., Ghanem E., Joshi A., Purtill J.J., Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin. Orthop. Relat. Res. 2008, 466:1710-1715.
32. Meadows S.E., Zuckerman J.D., Koval K.J. Posttraumatic tibial osteomyelitis: diagnosis, classification, and treatment. Bull. Hosp. Joint Dis. 1993, 52:11-16.
33. Mody R.M., Zapor M., Hartzell J.D., Robben P.M., Waterman P., Wood-Morris R., Trotta R., Andersen R.C., Wortmann G. Infectious complications of damage control orthopedics in war trauma. J. Trauma 2009, 67:758-761.
34. Moriarty T.F., Schlegel U., Perren S., Richards R.G. Infection in fracture fixation: can we influence infection rates through implant design?. J. Mater. Sci. Mater. Med. 2010, 21:1031-1035.
35. Ahmed S., Meghji S., Williams R.J., Henderson B., Brock J.H., Nair S.P. Staphylococcus aureus fibronectin binding proteins are essential for internalization by osteoblasts but do not account for differences in intracellular levels of bacteria. Infect. Immun. 2001, 69:2872-2877.
36. Hauck C.R., Ohlsen K. Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. Curr. Opin. Microbiol. 2006, 9:5-11.
37. Piroth L., Que Y.A., Widmer E., Panchaud A., Piu S., Entenza J.M., Moreillon P. The fibrinogen- and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis. Infect. Immun. 2008, 76:3824-3831.
38. Higgins D., Basaraba R., Hohnbaum A., Lee E., Grainger D., Gonzalez-Juarrero M. Localized immunosuppressive environment in the foreign body response to implanted biomaterials. Am. J. Pathol. 2009, 175:161-170.
39. Holt D., Chamberlain L., Grainger D. Cell-cell signaling in co-cultures of macrophages and fibroblasts. Biomaterials 2010, 31:9382-9394.
40. Zimmerli W., Sendi P. Pathogenesis of implant-associated infection: the role of the host. Semin. Immunopathol. 2011, 33:295-306.
41. Costerton J.W., Montanaro L., Arciola C.R. Biofilm in implant infections: its production and regulation. Int. J. Artif. Organs 2005, 28:1062-1068.
42. Delmi M., Vaudaux P., Lew D.P., Vasey H. Role of fibronectin in staphylococcal adhesion to metallic surfaces used as models of orthopaedic devices. J. Orthop. Res. 1994, 12:432-438.
43. Wyatt J.E., Poston S.M., Noble W.C. Adherence of Staphylococcus aureus to cell monolayers. J. Appl. Bacteriol. 1990, 69:834-844.
44. Pizarro-Cerda J., Cossart P. Bacterial adhesion and entry into host cells. Cell 2006, 124:715-727.
45. Isberg R.R., Hamburger Z., Dersch P. Signaling and invasin-promoted uptake via integrin receptors. Microbiol. Infect. 2000, 2:793-801.
46. Hauck C.R. Cell adhesion receptors - signaling capacity and exploitation by bacterial pathogens. Med. Microbiol. Immunol. 2002, 191:55-62.
47. Ellington J.K., Harris M., Hudson M.C., Vishin S., Webb L.X., Sherertz R. Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitis. J. Orthop. Res. 2006, 24:87-93.
48. Sinha B., Herrmann M. Mechanism and consequences of invasion of endothelial cells by Staphylococcus aureus. Thromb. Haemost. 2005, 94:266-277.
49. Baltch A.L., Bopp L.H., Smith R.P., Michelsen P.B., Ritz W.J. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes. J. Antimicrob. Chemother. 2005, 56:104-109.
50. Kaplan E.L., Chhatwal G.S., Rohde M. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin. Infect. Dis. 2006, 43:1398-1406. [see comment].
51. Schnaith A., Kashkar H., Leggio S.A., Addicks K., Kronke M., Krut O. Staphylococcus aureus subvert autophagy for induction of caspase-independent host cell death. J. Biol. Chem. 2007, 282:2695-2706.
52. Alexander E.H., Hudson M.C. Factors influencing the internalization of Staphylococcus aureus and impacts on the course of infections in humans. Appl. Microbiol. Biotechnol. 2001, 56:361-366.
53. Bost K.L., Ramp W.K., Nicholson N.C., Bento J.L., Marriott I., Hudson M.C. Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production. J. Infect. Dis. 1999, 180:1912-1920.
54. Ellington J.K., Harris M., Webb L., Smith B., Smith T., Tan K., Hudson M. Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis. J. Bone Joint Surg. Br. 2003, 85:918-921.
55. Ellington J.K., Reilly S.S., Ramp W.K., Smeltzer M.S., Kellam J.F., Hudson M.C. Mechanisms of Staphylococcus aureus invasion of cultured osteoblasts. Microb. Pathog. 1999, 26:317-323.
56. Garzoni C., Kelley W.L. Staphylococcus aureus: new evidence for intracellular persistence. Trends Microbiol. 2009, 17:59-65.
57. Krut O., Sommer H., Kronke M. Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells. J. Antimicrob. Chemother. 2004, 53:167-173.
58. Gosden P.E., MacGowan A.P., Bannister G.C. Importance of air quality and related factors in the prevention of infection in orthopaedic implant surgery. J. Hosp. Infect. 1998, 39:173-180.
59. Gristina A.G. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 1987, 237:1588-1595.
60. Subbiahdoss G., Kuijer R., Grijpma D., van der Mei H., Busscher H. Microbial biofilm growth vs. tissue integration: "The race for the surface" experimentally studied. Acta Biomater. 2009, 5:1399-1404.
61. Subbiahdoss G., Grijpma D., van der Mei H., Busscher H., Kuijer R. Microbial biofilm growth versus tissue integration on biomaterials with different wettabilities and a polymer-brush coating. J. Biomed. Mater. Res. A 2010, 94A:533-538.
62. Subbiahdoss G., Kiujer R., Busscher H., van der Mei H. Mammalian cell growth versus biofilm formation on biomaterial surfaces in an in vitro post-operative contamination model. Microbiology 2010, 156:3073-3078.
63. Franz S., Rammelt S., Scharnweber D., Simon J. Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 2011, 32:6692-6709.
64. Li D., Gromov K., Soballe K., Puzas J.E., O'Keefe R.J., Awad H., Drissi H., Schwarz E.M. Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity. J. Orthop. Res. 2008, 26:96-105.
65. Fink B., Grossmann A., Fuerst M., Schafer P., Frommelt L. Two-stage cementless revision of infected hip endoprostheses. Clin. Orthop. Relat. Res. 2009, 467:1848-1858.
66. Broekhuizen C.A., Schultz M.J., van der Wal A.C., Boszhard L., deBoer L., Vandenbroucke-Grauls C.M., Zaat S.A. Tissue around catheters is a niche for bacteria associated with medical device infection. Crit. Care Med. 2008, 36:2395-2402.
67. Broekhuizen C.A., Sta M., Vandenbroucke-Grauls C.M., Zaat S.A. Microscopic detection of viable Staphylococcus epidermidis in peri-implant tissue in experimental biomaterial-associated infection, identified by bromodeoxyuridine incorporation. Infect. Immun. 2010, 78:954-962.
68. Zaat S., Broekhuizen C., Riool M. Host tissue as a niche for biomaterial-associated infection. Future Microbiol. 2010, 5:1149-1151.
69. Elek S.D., Conen P.E. The virulence of Staphylococcus pyogenes for man: a study of the problems of wound infection. Br. J. Exp. Pathol. 1957, 38:573-586.
70. Lewis K. Multidrug tolerance of biofilms and persister cells. Curr. Top. Microbiol. Immunol. 2008, 322:107-131.
71. Aslam S. Effect of antibacterials on biofilms. Am. J. Infect. Control. 2008, 36. S175.e9-11.
72. Anderson G.G., O'Toole G.A. Innate and induced resistance mechanisms of bacterial biofilms. Curr. Top. Microbiol. Immunol. 2008, 322:85-105.
73. Stewart P.S., Davison W.M., Steenbergen J.N. Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm. Antimicrob. Agents Chemother. 2009, 53:3505-3507.
74. Smith K., Perez A., Ramage G., Gemmell C.G., Lang S. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int. J. Antimicrob. Agents 2009, 33:374-378.
75. Jain A., Gupta Y., Agrawal R., Khare P., Jain S.K. Biofilms - a microbial life perspective: a critical review. Crit. Rev. Ther. Drug Carrier Syst. 2007, 24:393-443.
76. Palmer J., Flint S., Brooks J. Bacterial cell attachment, the beginning of a biofilm. J. Ind. Microbiol. Biotechnol. 2007, 34:577-588.
77. Costerton J.W. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin. Orthop. Relat. Res. 2005, 437:7-11.
78. Bonazzi M., Cossart P. Bacterial entry into cells: a role for the endocytic machinery. FEBS Lett. 2006, 580:2962-2967.
79. Courtney H.S., Hasty D.L., Dale J.B. Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci. Ann. Med. 2002, 34:77-87.
80. Hudson M.C., Ramp W.K., Nicholson N.C., Williams A.S., Nousiainen M.T. Internalization of Staphylococcus aureus by cultured osteoblasts. Microb. Pathog. 1995, 19:409-419.
81. Khalil H., Williams R.J., Stenbeck G., Henderson B., Meghji S., Nair S.P. Invasion of bone cells by Staphylococcus epidermidis. Microbiol. Infect. 2007, 9:460-465.
82. Melcher G.A., Claudi B., Schlegel U., Perren S.M., Printzen G., Munzinger J. Influence of type of medullary nail on the development of local infection. An experimental study of solid and slotted nails in rabbits. J. Bone Joint Surg. Br. 1994, 76:955-959.
83. Arens S., Schlegel U., Printzen G., Ziegler W.J., Perren S.M., Hansis M. Influence of materials for fixation implants on local infection. An experimental study of steel versus titanium DCP in rabbits. J. Bone Joint Surg. Br. 1996, 78:647-651.
84. Yoshinari M., Oda Y., Kato T., Okuda K., Hirayama A. Influence of surface modification to titanium on oral bacterial adhesion in vitro. J. Biomed. Mater. Res. 2000, 52:388-394.
85. Duarte P.M., Reis A.F., DeFreitas P.M., Ota-Tsuzuki C. Bacterial adhesion on smooth and rough titanium surfaces after treatment with different instruments. J. Periodontol. 2009, 80:1824-1832.
86. Harris L.G., Richards R.G. Staphylococcus aureus adhesion to different treated titanium surfaces. J. Mater. Sci. Mater. Med. 2004, 15:311-314.
87. Kouidhi B., Zmantar T., Hentati H., Bakhrouf A. Cell surface hydrophobicity, biofilm formation, adhesives, properties and molecular detection of adhesins genes in Staphylococcus aureus associated to dental caries. Microb. Pathog. 2010, 49:14-22.
88. Boks N.P., Norde W., van der Mei H.C., Bussher H.J. Forces involved in bacterial adhesion to hydrophilic and hydrophobic surfaces. Microbiology 2008, 154:3122-3133.
89. Boks N.P., Kaper H.J., Norde W., Van der Mei H.C., Busscher H.J. Mobile and immobile adhesion of staphylococcal strains to hydrophilic and hydrophobic surfaes. J. Colloid Interface Sci. 2009, 331:60-64.
90. Buser D., Schenk R.K., Steinemann S., Fiorellini J.P., Fox C.H., Stich H. Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. J. Biomed. Mater. Res. 1991, 25:889-902.
91. Galante J.O., Jacobs J. Clinical performances of ingrowth surfaces. Clin. Orthop. Relat. Res. 1992, 276:41-49.
92. Lincks J., Boyan B.D., Blanchard C.R., Lohmann C.H., Liu Y., Cochran D.L., Dean D.D., Schwartz Z. Response of MG63 osteoblast-like cells to titanium and titanium alloy is dependent on surface roughness and composition. Biomaterials 1998, 19:2219-2232.
93. Puleo D.A., Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 1999, 20:2311-2321.
94. Ducheyne P., Hench L.L., Kagan A., Martens M., Bursens A., Mulier J.C. Effect of hydroxyapatite impregnation on skeletal bonding of porous coated implants. J. Biomed. Mater. Res. 1980, 14:225-237.
95. Ducheyne P., Beight J., Cuckler J., Evans B., Radin S. Effect of calcium phosphate coating characteristics on early post-operative bone tissue ingrowth. Biomaterials 1990, 11:531-540.
96. Block M.S., Finger I.M., Fontenot M.G., Kent J.N. Loaded hydroxylapatite-coated and grit-blasted titanium implants in dogs. Int. J. Oral. Maxillofac. Implants 1989, 4:219-225.
97. Bloebaum R.D., Beeks D., Dorr L.D., Savory C.G., DuPont J.A., Hofmann A.A. Complications with hydroxyapatite particulate separation in total hip arthroplasty. Clin. Orthop. Relat. Res. 1994, 298:19-26.
98. Raulio M., Jarn M., Ahola J., Peltonen J., Rosenholm J.B., Tervakangas S., Kolehmainen J., Ruokolainen T., Narko P., Salkinoja-Salonen M. Microbe repelling coated stainless steel analysed by field emission scanning electron microscopy and physicochemical methods. J. Ind. Microbiol. Biotechnol. 2008, 35:751-760.
99. Riedewald F. Bacterial adhesion to surfaces: the influence of surface roughness. PDA J. Pharm. Sci. Technol. 2006, 60:164-171.
100. Oga M., Arizono T., Sugioka Y. Bacterial adherence to bioinert and bioactive materials studied in vitro. Acta Orthop. Scand. 1993, 64:273-276.
101. Arciola C.R., Montanaro L., Moroni A., Giordano M., Pizzoferrato A., Donati M.E. Hydroxyapatite-coated orthopaedic screws as infection resistant materials: in vitro study. Biomaterials 1999, 20:323-327.
102. Buranapanitkit B., Srinilta V., Ingviga N., Oungbho K., Geater A., Ovatlarnporn C. The efficacy of a hydroxyapatite composite as a biodegradable antibiotic delivery system. Clin. Orthop. Relat. Res. 2004, 424:244-252.
103. Rauschmann M.A., Wichelhaus T.A., Stirnal V., Dingeldein E., Zichner L., Schnettler R., Alt V. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 2005, 26:2677-2684.
104. Shirtliff M.E., Calhoun J.H., Mader J.T. Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite. Clin. Orthop. Relat. Res. 2002, 401:239-247.
105. Baldwin C.L., Goenka R. Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection?. Crit. Rev. Immunol. 2006, 26:407-442.
106. Anderson J.A., Sculco P.K., Heitkemper S., Mayman D.J., Bostrom M.P., Sculco T.P. An articulating spacer to treat and mobilize patients with infected total knee arthroplasty. J. Arthroplasty 2009, 24:631-635.
107. Puckett S.D., Taylor E., Raimondo T., Webster T.J. The relationship between the nanostructure of titanium surfaces and bacterial attachment. Biomaterials 2010, 31:706-713.
108. Ivanova E.P., Truong V.K., Wang J.Y., Berndt C.C., Jones R.T., Yusuf I.I., Peake I., Schmidt H.W., Fluke C., Barnes D., Crawford R.J. Impact of nanoscale roughness of titanium thin film surfaces on bacterial retention. Langmuir 2010, 26:1973-1982.
109. Truong V.K., Lapovok R., Estrin Y.S., Rundell S., Wang J.Y., Fluke C.J., Crawford R.J., Ivanova E.P. The influence of nano-scale surface roughness on bacterial adhesion to ultrafine-grained titanium. Biomaterials 2010, 31:3674-3683.
110. Chung K.K., Schumacher J.F., Sampson E.M., Burne R.A., Antonelli P.J., Brennan A.B. Impact of engineered surface microtopography on biofilm formation of Staphylococcus aureus. Biointerphases 2007, 2:89-94.
111. Lord C., Gebhardt M., Tomford W., Mankin H. Infection in bone allografts. Incidence, nature, and treatment. J. Bone Joint Surg. Am. 1988, 70:369-376.
112. Mankin H.J., Doppelt S., Tomford W.W. Clinical experience with allograft implantation. The first ten years. Clin. Orthop. Relat. Res. 1983, 174:69-86.
113. Buttaro M.A., Morandi A., Rivello H.G., Piccaluga F. Histology of vancomycin-supplemented impacted bone allografts in revision total hip arthroplasty. J. Bone Joint Surg. Br. 2005, 87:1684-1687.
114. Hilpert K., Elliott M., Jenssen H., Kindrachuk J., Fjell C.D., Korner J., Winkler D.F., Weaver L.L., Henklein P., Ulrich A.S., Chiang S.H., Farmer S.W., Pante N., Volkmer R., Hancock R.E. Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. Chem. Biol. 2009, 16:58-69.
115. Spivak J.M., Petrizzo A.M. Revision of a lumbar disc arthroplasty following late infection. Eur. Spine J. 2010, 19:677-681.
116. Sierra-Hoffman M., Jinadatha C., Carpenter J.L., Rahm M. Postoperative instrumented spine infections: a retrospective review. South. Med. J. 2010, 103:25-30.
117. Kim J.I., Suh K.T., Kim S.J., Lee J.S. Implant removal for the management of infection after instrumented spinal fusion. J. Spinal Disord. Tech. 2010, 23:258-265.
118. Betsch B.Y., Eggli S., Siebenrock K.A., Tauber M.G., Muhlemann K. Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin. Infect. Dis. 2008, 46:1221-1226.
119. Hanssen A.D. Managing the infected knee: as good as it gets. J. Arthroplasty 2002, 17:98-101.
120. Sukeik M., Haddad F.S. Two-stage procedure in the treatment of late chronic hip infections - spacer implantation. Int. J. Med. Sci. 2009, 6:253-257.
121. Lazennec J.Y., Fourniols E., Lenoir T., Aubry A., Pissonnier M.L., Issartel B., Rousseau M.A. Infections in the operated spine: update on risk management and therapeutic strategies. Orthop. Traumatol. Surg. Res. 2011, 97:373-380.
122. De Grood M.P. Pathology, diagnosis and treatment of subdural empyema. Arch. Chir. Neerl. 1951, 3:128-138.
123. Buttaro M.A., Pusso R., Piccaluga F. Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty: two-stage revision results. J. Bone Joint Surg. Br. 2005, 87-B:314-319.
124. Humphrey J.S., Mehta S., Seaber A.V., Vail T.P. Pharmacokinetics of a degradable drug delivery system in bone. Clin. Orthop. Relat. Res. 1998, 349:218-224.
125. Kanellakopoulou K., Giamarellos-Bourboulis E.J. Carrier systems for the local delivery of antibiotics in bone infections. Drugs 2000, 59:1223-1232.
126. Rushton N. Applications of local antibiotic therapy. Eur. J. Surg. Suppl. 1997, 578:27-30.
127. Suh H., Suh S., Min B. Anti-infection treatment of a transcutaneous device by a collagen-rifampicin composite. ASAIO J. 1994, 40:M406-M411.
128. Wachol-Drewek Z., Pfeiffer M., Scholl E. Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin. Biomaterials 1996, 17:1733-1738.
129. Ambrose C.G., Clyburn T.A., Louden K., Joseph J., Wright J., Gulati P., Gogola G.R., Mikos A.G. Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model. Clin. Orthop. Relat. Res. 2004, 421:293-299.
130. Billon A., Chabaud L., Gouyette A., Bouler J.M., Merle C. Vancomycin biodegradable poly(lactide-co-glycolide) microparticles for bone implantation. Influence of the formulation parameters on the size, morphology, drug loading and in vitro release. J. Microencapsul. 2005, 22:841-852.
131. Calhoun J.H., Mader J.T. Treatment of osteomyelitis with a biodegradable antibiotic implant. Clin. Orthop. Relat. Res. 1997, 341:206-214.
132. Kalicke T., Schierholz J., Schlegel U., Frangen T.M., Koller M., Printzen G., Seybold D., Klockner S., Muhr G., Arens S. Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study. J. Orthop. Res. 2006, 24:1622-1640.
133. Gitelis S., Brebach G.T. The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J. Orthop. Surg. 2002, 10:53-60.
134. Witsø E., Persen L., Benum P., Bergh K. Release of netilmicin and vancomycin from cancellous bone. Acta Orthop. Scand. 2002, 73:199-205.
135. Tomford W., Thongphasuk J., Mankin H., Ferraro M. Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use. J. Bone Joint Surg. Am. 1990, 72:1137-1143.
136. Kuijpers A.J., Engbers G.H., van Wachem P.B., Krijgsveld J., Zaat S.A., Dankert J., Feijen J. Controlled delivery of antibacterial proteins from biodegradable matrices. J. Control. Release. 1998, 53:235-247.
137. Neut D., van de Belt H., Stokroos I., van Horn J.R., van der Mei H.C., Busscher H.J. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J. Antimicrob. Chemother. 2001, 47:885-891.
138. Fu J., Ji J., Fan D., Shen J. Construction of antibacterial multilayer films containing nanosilver via layer-by-layer assembly of heparin and chitosan-silver ions complex. J. Biomed. Mater. Res. A 2006, 79:665-674.
139. Antoci V., Adams C.S., Hickok N.J., Shapiro I.M., Parvizi J. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin. Orthop. Relat. Res. 2007, 462:200-206.
140. Witso E., Persen L., Benum P., Bergh K. Cortical allograft as a vehicle for antibiotic delivery. Acta Orthop. 2005, 76:481-486.
141. Gray J.C., Elves M.W. Osteogenesis in bone grafts after short-term storage and topical antibiotic treatment. An experimental study in rats. J. Bone Joint Surg. Br. 1981, 63:441-445.
142. Isefuku S., Joyner C.J., Simpson A.H. Toxic effect of rifampicin on human osteoblast-like cells. J. Orthop. Res. 2001, 19:950-954.
143. Edin M.L., Miclau T., Lester G.E., Lindsey R.W., Dahners L.E. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin. Orthop. Relat. Res. 1996, 333:245-251.
144. Antoci V., Adams C.S., Parvizi J., Ducheyne P., Shapiro I.M., Hickok N.J. Covalently attached vancomycin provides a nanoscale antibacterial surface. Clin. Orthop. Relat. Res. 2007, 461:81-87.
145. Antoci V., King S.B., Jose B., Parvizi J., Zeiger A.R., Wickstrom E., Freeman T.A., Composto R.J., Ducheyne P., Shapiro I.M., Hickok N.J., Adams C.S. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J. Orthop. Res. 2007, 25:858-866.
146. Fiorilli S., Rivolo P., Descrovi E., Riccardi C., Pasquardisi L., Lunelli L., Vanzetto l., Perzoolli C., Onida B., Garron E. Vapor phase self-assembled monolayers of aminosilane on plasma activated silicon substrate. J. Colloid Interface Sci. 2008, 321:235-241.
147. Adams C.S., Antoci V., Harrison G., Patal P., Freeman T.A., Shapiro I.M., Parvizi J., Hickok N.J., Radin S., Ducheyne P. Controlled release of vancomycin from thin sol-gel films on implant surfaces successfully controls osteomyelitis. J. Orthop. Res. 2009, 27:701-709.
148. Antoci V., Adams C.S., Hickok N.J., Shapiro I.M., Parvizi J. Vancomycin bound to Ti rods reduces periprosthetic infection: preliminary study. Clin. Orthop. Relat. Res. 2007, 461:88-95.
149. Massia S.P., Hubbell J.A. Covalent surface immobilization of Arg-Gly-Asp- and Tyr-Ile-Gly-Ser-Arg-containing peptides to obtain well-defined cell-adhesive substrates. Anal. Biochem. 1990, 187:292-301.
150. Rezania A., Thomas C.H., Branger A.B., Waters C.M., Healy K.E. The detachment strength and morphology of bone cells contacting materials modified with a peptide sequence found within bone sialoprotein. J. Biomed. Mater. Res. 1997, 37:9-19.
151. Rezania A., Healy K.E. Biomimetic peptide surfaces that regulate adhesion, spreading, cytoskeletal organization, and mineralization of the matrix deposited by osteoblast-like cells. Biotechnol. Prog. 1999, 15:19-32.
152. Rezania A., Healy K.E. The effect of peptide surface density on mineralization of a matrix deposited by osteogenic cells. J. Biomed. Mater. Res. 2000, 52:595-600.
153. Derda R., Wherritt D.J., Kiessling L.L. Solid-phase synthesis of alkanethiols for the preparation of self-assembled monolayers. Langmuir 2007, 23:11164-11167.
154. Cavalcanti-Adam E.A., Shapiro I.M., Composto R.J., Macarak E.J., Adams C.S. RGD peptides immobilized on a mechanically deformable surface promote osteoblast differentiation. J. Bone Miner. Res. 2002, 17:2130-2140.
155. El-Ghannam A.R., Ducheyne P., Risbud M., Adams C.S., Shapiro I.M., Castner D., Golledge S., Composto R.J. Model surfaces engineered with nanoscale roughness and RGD tripeptides promote osteoblast activity. J. Biomed. Mater. Res. A 2004, 68:615-627.
156. Secchi A.G., Grigoriou V., Shapiro I.M., Cavalcanti-Adam E.A., Composto R.J., Ducheyne P., Adams C.S. RGDS peptides immobilized on titanium alloy stimulate bone cell attachment, differentiation and confer resistance to apoptosis. J. Biomed. Mater. Res. A 2007, 83:577-584.
157. Ferris D.M., Moodie G.D., Dimond P.M., Gioranni C.W., Ehrlich M.G., Valentini R.F. RGD-coated titanium implants stimulate increased bone formation in vivo. Biomaterials 1999, 20:2323-2331.
158. Okamoto K., Matsuura T., Hosokawa R., Akagawa Y. RGD peptides regulate the specific adhesion scheme of osteoblasts to hydroxyapatite but not to titanium. J. Dent. Res. 1998, 77:481-487.
159. Danahy M.P., Avaltroni M.J., Midwood K.S., Schwarbauer J.E., Schwartz J. Self-assembled monolayers of alpha, omega-diphosphonic acids on Ti enable complete or spatially controlled surface derivatization. Langmuir 2004, 20:5333-5337.
160. Heijink A., Schwartz J., Zobitz M.E., Nicole Crowder K., Lutz G.E., Sibonga J.D. Self-assembled monolayer films of phosphonates for bonding RGD to titanium. Clin. Orthop. Relat. Res. 2008, 466:977-984.
161. Puleo D.A., Kissling R.A., Sheu M.S. A technique to immobilize bioactive proteins, including bone morphogenetic protein-4 (BMP-4) on titanium alloy. Biomaterials 2002, 23:2079-2087.
162. Wojcik S.M., Puleo D.A. Biochemical surface modification of Ti-6Al-4V for the delivery of protein to the cell-biomaterial interface. Biomed. Sci. Instrum. 1997, 33:166-171.
163. Lawson M.C., Bowman C.N., Anseth K.S. Vancomycin derivative photopolymerized to titanium kills S. epidermidis. Clin. Orthop. Relat. Res. 2007, 461:96-105.
164. Mikulec L.J., Puleo D.A. Use of p-nitrophenyl chloroformate chemistry to immobilize protein on orthopedic biomaterials. J. Biomed. Mater. Res. 1996, 32:203-208.
165. Khoo X., Hamilton P., O'Toole G.A., Snyder B.D., Kenan D.J., Grinstaff M.W. Directed assembly of PEGylated-peptide coatings for infection-resistant titanium metal. J. Am. Chem. Soc. 2009, 131:10992-10997.
166. Gabriel M., Nazmi K., Veerman E.C., Nieuw Amerongen A.V., Zentner A. Preparation of LL-37-grafted titanium surfaces with bactericidal activity. Bioconjug. Chem. 2006, 17:548-550.
167. Humblot V., Yala J.F., Thebault P., Boukerma K., Hequet A., Berjeaud J.M., Pradier C.M. The antibacterial activity of Magainin I immobilized onto mixed thiols self-assembled monolayers. Biomaterials 2009, 30:3503-3512.
168. Parvizi J., Wickstrom E., Zeiger A.R., Adams C.S., Shapiro I.M., Purtill J.J., Sharkey P.F., Hozack W.J., Rothman R.H., Hickok N.J. Frank Stinchfield Award. Titanium surface with biologic activity against infection. Clin. Orthop. Relat. Res. 2004, 429:33-38.
169. Jose B., Antoci V., Zeiger A.R., Wickstrom E., Hickok N.J. Vancomycin covalently bonded to titanium beads kills Staphylococcus aureus. Chem. Biol. 2005, 12:1041-1048.
170. Lawson M.C., Hoth K.C., Deforest C.A., Bowman C.N., Anseth K.S. Inhibition of Staphylococcus epidermidis biofilms using polymerizable vancomycin derivatives. Clin. Orthop. Relat. Res. 2010, 468:2081-2091.
171. Chen C.P., Wickstrom E. Self-protecting bactericidal titanium alloy surface formed by covalent bonding of daptomycin bisphosphonates. Bioconjug. Chem. 2010, 21:1978-1986.
172. Edupuganti O.P., Antoci V., King S.B., Jose B., Adams C.S., Parvizi J., Shapiro I.M., Zeiger A.R., Hickok N.J., Wickstrom E. Covalent bonding of vancomycin to Ti6Al4V alloy pins provides long-term inhibition of Staphylococcus aureus colonization. Bioorg. Med. Chem. Lett. 2007, 17:2692-2696.
173. Ketonis C., Adams C.S., Barr S., Aiyer A., Shapiro I.M., Parvizi J., Hickok N.J. Antibiotic modification of native grafts: improving upon nature's scaffolds. Tissue Eng. Part A 2010, 16:2041-2049.
174. Lee M.H., Brass D.A., Morris R., Composto R.J., Ducheyne P. The effect of non-specific interactions on cellular adhesion using model surfaces. Biomaterials 2005, 26:1721-1730.
175. Puleo D.A. Retention of enzymatic activity immobilized on silanized Co-Cr-Mo and Ti-6Al-4V. J. Biomed. Mater. Res. 1997, 37:222-228.
176. Ketonis C., Parvizi J., Adams C.S., Shapiro I.M., Hickok N.J. Topographic features retained after antibiotic modification of Ti alloy surfaces. Clin. Orthop. Relat. Res. 2009, 467:1678-1687.
177. Antoci V., Adams C.S., Parvizi J., Davidson H.M., Composto R.J., Freeman T.A., Wickstrom E., Zeiger A.R., Ducheyne P., Jungkind D., Shapiro I.M., Hickok N.J. Vancomycin-modified Ti alloy inhibits S. epidermidis biofilm formation: implications for treatment of periprosthetic infection. Biomaterials 2008, 29:4684-4690.
178. Loll P.J., Axelsen P.H. The structural biology of molecular recognition by vancomycin. Annu. Rev. Biophys. Biomol. Struct. 2000, 29:265-289.
179. Ketonis C., Barr S., Adams C.S., Shapiro I.M., Parvizi J., Hickok N.J. Vancomycin bonded to bone grafts prevents bacterial colonization. Antimicrob. Agents Chemother. 2011, 55:487-494.
180. Lawson M.C., Shoemaker R., Hoth K.B., Bowman C.N., Anseth K.S. Polymerizable vancomycin derivatives for bactericidal biomaterial surface modification: structure-function evaluation. Biomacromolecules 2009, 10:2221-2234.
181. Sykes R.B. The 2009 Garrod lecture: the evolution of antimicrobial resistance: a Darwinian perspective. J. Antimicrob. Chemother. 2010, 65:1842-1852.
182. Wimpenny J. Microbial metropolis. Adv. Microb. Physiol. 2009, 56:29-84.